Centene Corp (CNC)vsProgyny Inc (PGNY)
CNC
Centene Corp
$32.73
-0.76%
HEALTHCARE · Cap: $16.10B
PGNY
Progyny Inc
$17.75
-1.66%
HEALTHCARE · Cap: $1.48B
Smart Verdict
WallStSmart Research — data-driven comparison
Centene Corp generates 13569% more annual revenue ($176.15B vs $1.29B). PGNY leads profitability with a 4.5% profit margin vs -3.8%. CNC earns a higher WallStSmart Score of 65/100 (B-).
CNC
Strong Buy65
out of 100
Grade: B-
PGNY
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CNC.
Margin of Safety
+16.6%
Fair Value
$25.84
Current Price
$17.75
$8.09 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Growing faster than its price suggests
Revenue surging 23.2% year-over-year
Earnings expanding 21.8% YoY
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Earnings expanding 20.6% YoY
Areas to Watch
ROE of -28.7% — below average capital efficiency
Currently unprofitable
Operating margin of -1.9%
Moderate valuation
Smaller company, higher risk/reward
4.5% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CNC
The strongest argument for CNC centers on Price/Book, PEG Ratio, Revenue Growth. Revenue growth of 23.2% demonstrates continued momentum. PEG of 0.74 suggests the stock is reasonably priced for its growth.
Bull Case : PGNY
The strongest argument for PGNY centers on Altman Z-Score, Price/Book, EPS Growth.
Bear Case : CNC
The primary concerns for CNC are Return on Equity, Profit Margin, Operating Margin.
Bear Case : PGNY
The primary concerns for PGNY are P/E Ratio, Market Cap, Profit Margin. Thin 4.5% margins leave little buffer for downturns.
Key Dynamics to Monitor
CNC profiles as a growth stock while PGNY is a value play — different risk/reward profiles.
PGNY carries more volatility with a beta of 1.01 — expect wider price swings.
CNC is growing revenue faster at 23.2% — sustainability is the question.
CNC generates stronger free cash flow (224M), providing more financial flexibility.
Bottom Line
CNC scores higher overall (65/100 vs 50/100) and 23.2% revenue growth. PGNY offers better value entry with a 16.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centene Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.
Progyny Inc
HEALTHCARE · HEALTHCARE PLANS · USA
Progyny, Inc., a benefits management company, specializes in fertility benefits and family development solutions for employers in the United States. The company is headquartered in New York, New York.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?